Type 2 diabetes and anti-diabetic medications modify the risk of liver-related outcomes in subjects with non-alcoholic fatty liver disease and advanced fibrosis. Results of a multicenter international cohort study

Luis C. Bertot, Eduardo Vilar Gomez, Vincent W. Wong, Marlen Castellanos Fernandez, Rocio Aller, Mohammed Eslam, Jacob George, Manuel Romero-Gomez, Leon A. Adams

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Pages (from-to)1119A-1119A
Number of pages1
Publication statusPublished - Oct 2017
Event68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting - Washington, United States
Duration: 20 Oct 201724 Oct 2017

Cite this